Atorvastatin calcium - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for atorvastatin calcium and what is the scope of patent protection?
Atorvastatin calcium
is the generic ingredient in four branded drugs marketed by Accord Hlthcare, Agnitio, Alkem Labs Ltd, Apotex Inc, Biocon Pharma, Dr Reddys, Dr Reddys Labs Ltd, Graviti Pharms, Invagen Pharms, Lannett Co Inc, Lepu Pharm, Lupin Ltd, Micro Labs Ltd India, MSN, Mylan Pharms Inc, Perrigo R And D, Sandoz Inc, Sciegen Pharms Inc, Sun Pharm Inds Ltd, Teva Pharms, Teva Pharms Usa, Umedica Labs Pvt Ltd, Zydus Pharms, Upjohn, Organon, and Scov3, and is included in twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.There are fifty-five drug master file entries for atorvastatin calcium. Fifty-eight suppliers are listed for this compound.
Summary for atorvastatin calcium
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 26 |
NDAs: | 27 |
Drug Master File Entries: | 55 |
Finished Product Suppliers / Packagers: | 58 |
Raw Ingredient (Bulk) Api Vendors: | 85 |
Clinical Trials: | 66 |
Patent Applications: | 6,886 |
Formulation / Manufacturing: | see details |
Drug Sales Revenues: | Drug sales revenues for atorvastatin calcium |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for atorvastatin calcium |
What excipients (inactive ingredients) are in atorvastatin calcium? | atorvastatin calcium excipients list |
DailyMed Link: | atorvastatin calcium at DailyMed |
Recent Clinical Trials for atorvastatin calcium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Stony Brook University | Phase 3 |
Odense Patient Data Explorative Network | N/A |
Odense University Hospital | N/A |
Pharmacology for atorvastatin calcium
Drug Class | HMG-CoA Reductase Inhibitor |
Mechanism of Action | Hydroxymethylglutaryl-CoA Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for atorvastatin calcium
US Patents and Regulatory Information for atorvastatin calcium
Expired US Patents for atorvastatin calcium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Upjohn | LIPITOR | atorvastatin calcium | TABLET;ORAL | 020702-004 | Apr 7, 2000 | See Plans and Pricing | See Plans and Pricing |
Upjohn | LIPITOR | atorvastatin calcium | TABLET;ORAL | 020702-002 | Dec 17, 1996 | See Plans and Pricing | See Plans and Pricing |
Upjohn | LIPITOR | atorvastatin calcium | TABLET;ORAL | 020702-003 | Dec 17, 1996 | See Plans and Pricing | See Plans and Pricing |
Upjohn | LIPITOR | atorvastatin calcium | TABLET;ORAL | 020702-002 | Dec 17, 1996 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.